Skip to main content
OpenTrials

Clinical trial condition

Marginal Zone Lymphoma(MZL)

Explore clinical trials studying Marginal Zone Lymphoma(MZL). Study availability and eligibility vary by location and protocol.

14 public trials 8 recruiting studies

Marginal Zone Lymphoma(MZL) trial results

Conditions
Blood Protein Disorders, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +32 more
Locations
  • Norton Cancer Institute, St. Matthews Campus Louisville, Kentucky, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • The Ohio State University Columbus, Ohio, United States
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Shanghai Ruijin Hospital Shanghai, China
  • Affiliated First Hospital of China Medical University Shenyang, Liaoning, China
  • Peking University Third Hospital Beijing, China
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
  • Dongyang People's Hospital Dongyang, China
  • Affiliated Hangzhou First People's Hospital Hangzhou, China
  • Zhejiang cancer Hospital Hangzhou, China
View all 18 locations
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • AOU SS Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • IRCCS-AOU di Bologna Bologna, Italy
  • P.O. Garibaldi-Nesima_UOC Ematologia Catania, Italy
  • AO di Cosenza, P.O. "Annunziata" - UOC di Ematologia Cosenza, Italy
View all 15 locations